14 mill MC 22 mill cash
Like I said they might have gotten rid of Jason and Alex to streamline costs, smartest thing to do is JV with some large pharma let them run trials we get 40% royalty and they get 60% of drug (sell it to them). Im sure they would run the trial better than the plebs we had here doing it. Large pharma smashes through trials successfully, drug passes through we get royalties.
Then do the same thing with TBI.
Essentially we could become a royalty company where our drug is owned majority by a large pharma and let them do all the ground work and we get royalties off it (say 40%) and then if one day they want to buy the rest of our posi, we get taken over still multiples of where we are.
So many possibilities they have. hence why they still have Tom there, Tom to deal like he did with Sirtex and sell this asset off essentially making us the subsidiary.
Hoping something like that happens, let a big pharma take control
Im sure Tattarang would be wanting his $1.30 raise money back + some.
- Forums
- ASX - By Stock
- IXC
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-8
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.6¢ |
Change
0.002(2.70%) |
Mkt cap ! $5.712M |
Open | High | Low | Value | Volume |
7.0¢ | 7.6¢ | 7.0¢ | $9.48K | 128.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 2272 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 31115 | 0.071 |
1 | 100000 | 0.070 |
1 | 10000 | 0.051 |
1 | 200000 | 0.050 |
1 | 60001 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 2272 | 1 |
0.076 | 14470 | 2 |
0.077 | 7950 | 1 |
0.078 | 20000 | 1 |
0.080 | 10000 | 1 |
Last trade - 10.51am 24/06/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |